The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells.
about
The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The combination therapy of sal ...... r stem cells and cancer cells.
@en
The combination therapy of sal ...... r stem cells and cancer cells.
@nl
type
label
The combination therapy of sal ...... r stem cells and cancer cells.
@en
The combination therapy of sal ...... r stem cells and cancer cells.
@nl
prefLabel
The combination therapy of sal ...... r stem cells and cancer cells.
@en
The combination therapy of sal ...... r stem cells and cancer cells.
@nl
P2093
P2860
P356
P1476
The combination therapy of sal ...... r stem cells and cancer cells.
@en
P2093
P2860
P304
P356
10.2147/OTT.S141083
P407
P577
2017-11-27T00:00:00Z